Global Fragment-based Drug Discovery Market Size, Status and Forecast 2020-2026

Global Fragment-based Drug Discovery Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Fragment Screening
1.3.3 Fragment Optimization
1.4 Market by Application
1.4.1 Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2026
1.4.2 Academic and Research Institutions
1.4.3 Biopharmaceutical Companies
1.4.4 Contract Research Organizations (CROs)
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fragment-based Drug Discovery Market Perspective (2015-2026)
2.2 Fragment-based Drug Discovery Growth Trends by Regions
2.2.1 Fragment-based Drug Discovery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fragment-based Drug Discovery Historic Market Share by Regions (2015-2020)
2.2.3 Fragment-based Drug Discovery Forecasted Market Size by Regions (2021-2026)
2.3 Fragment-based Drug Discovery Industry Dynamic
2.3.1 Fragment-based Drug Discovery Market Trends
2.3.2 Fragment-based Drug Discovery Market Drivers
2.3.3 Fragment-based Drug Discovery Market Challenges
2.3.4 Fragment-based Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fragment-based Drug Discovery Players by Market Size
3.1.1 Global Top Fragment-based Drug Discovery Players by Revenue (2015-2020)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Players (2015-2020)
3.2 Global Fragment-based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fragment-based Drug Discovery Revenue
3.4 Global Fragment-based Drug Discovery Market Concentration Ratio
3.4.1 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fragment-based Drug Discovery Revenue in 2019
3.5 Key Players Fragment-based Drug Discovery Area Served
3.6 Key Players Fragment-based Drug Discovery Product Solution and Service
3.7 Date of Enter into Fragment-based Drug Discovery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fragment-based Drug Discovery Breakdown Data by Type
4.1 Global Fragment-based Drug Discovery Historic Market Size by Type (2015-2020)
4.2 Global Fragment-based Drug Discovery Forecasted Market Size by Type (2021-2026)
5 Fragment-based Drug Discovery Breakdown Data by Application
5.1 Global Fragment-based Drug Discovery Historic Market Size by Application (2015-2020)
5.2 Global Fragment-based Drug Discovery Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Fragment-based Drug Discovery Market Size (2015-2026)
6.2 North America Fragment-based Drug Discovery Market Size by Type (2015-2020)
6.3 North America Fragment-based Drug Discovery Market Size by Application (2015-2020)
6.4 North America Fragment-based Drug Discovery Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Fragment-based Drug Discovery Market Size (2015-2026)
7.2 Europe Fragment-based Drug Discovery Market Size by Type (2015-2020)
7.3 Europe Fragment-based Drug Discovery Market Size by Application (2015-2020)
7.4 Europe Fragment-based Drug Discovery Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fragment-based Drug Discovery Market Size (2015-2026)
8.2 Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2015-2020)
8.3 Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2015-2020)
8.4 Asia-Pacific Fragment-based Drug Discovery Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Fragment-based Drug Discovery Market Size (2015-2026)
9.2 Latin America Fragment-based Drug Discovery Market Size by Type (2015-2020)
9.3 Latin America Fragment-based Drug Discovery Market Size by Application (2015-2020)
9.4 Latin America Fragment-based Drug Discovery Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fragment-based Drug Discovery Market Size (2015-2026)
10.2 Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2015-2020)
10.3 Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2015-2020)
10.4 Middle East & Africa Fragment-based Drug Discovery Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Astex Pharmaceuticals
11.1.1 Astex Pharmaceuticals Company Details
11.1.2 Astex Pharmaceuticals Business Overview
11.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Introduction
11.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020))
11.1.5 Astex Pharmaceuticals Recent Development
11.2 Alveus Pharmaceuticals
11.2.1 Alveus Pharmaceuticals Company Details
11.2.2 Alveus Pharmaceuticals Business Overview
11.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Introduction
11.2.4 Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.2.5 Alveus Pharmaceuticals Recent Development
11.3 Beactica
11.3.1 Beactica Company Details
11.3.2 Beactica Business Overview
11.3.3 Beactica Fragment-based Drug Discovery Introduction
11.3.4 Beactica Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.3.5 Beactica Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Fragment-based Drug Discovery Introduction
11.4.4 Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.4.5 Charles River Laboratories Recent Development
11.5 Crown Bioscience
11.5.1 Crown Bioscience Company Details
11.5.2 Crown Bioscience Business Overview
11.5.3 Crown Bioscience Fragment-based Drug Discovery Introduction
11.5.4 Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.5.5 Crown Bioscience Recent Development
11.6 Emerald BioStructures
11.6.1 Emerald BioStructures Company Details
11.6.2 Emerald BioStructures Business Overview
11.6.3 Emerald BioStructures Fragment-based Drug Discovery Introduction
11.6.4 Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.6.5 Emerald BioStructures Recent Development
11.7 Evotec
11.7.1 Evotec Company Details
11.7.2 Evotec Business Overview
11.7.3 Evotec Fragment-based Drug Discovery Introduction
11.7.4 Evotec Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.7.5 Evotec Recent Development
11.8 Kinetic Discovery
11.8.1 Kinetic Discovery Company Details
11.8.2 Kinetic Discovery Business Overview
11.8.3 Kinetic Discovery Fragment-based Drug Discovery Introduction
11.8.4 Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.8.5 Kinetic Discovery Recent Development
11.9 Proteros Fragments
11.9.1 Proteros Fragments Company Details
11.9.2 Proteros Fragments Business Overview
11.9.3 Proteros Fragments Fragment-based Drug Discovery Introduction
11.9.4 Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.9.5 Proteros Fragments Recent Development
11.10 Sprint Bioscience
11.10.1 Sprint Bioscience Company Details
11.10.2 Sprint Bioscience Business Overview
11.10.3 Sprint Bioscience Fragment-based Drug Discovery Introduction
11.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020)
11.10.5 Sprint Bioscience Recent Development
11.11 Structure Based Design
10.11.1 Structure Based Design Company Details
10.11.2 Structure Based Design Business Overview
10.11.3 Structure Based Design Fragment-based Drug Discovery Introduction
10.11.4 Structure Based Design Revenue in Fragment-based Drug Discovery Business (2015-2020)
10.11.5 Structure Based Design Recent Development
11.12 Sygnature Discovery
10.12.1 Sygnature Discovery Company Details
10.12.2 Sygnature Discovery Business Overview
10.12.3 Sygnature Discovery Fragment-based Drug Discovery Introduction
10.12.4 Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020)
10.12.5 Sygnature Discovery Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Fragment-based Drug Discovery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Fragment Screening
Table 3. Key Players of Fragment Optimization
Table 4. Global Fragment-based Drug Discovery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 5. Global Fragment-based Drug Discovery Market Size by Regions (US$ Million): 2020 VS 2026
Table 6. Global Fragment-based Drug Discovery Market Size by Regions (2015-2020) (US$ Million)
Table 7. Global Fragment-based Drug Discovery Market Share by Regions (2015-2020)
Table 8. Global Fragment-based Drug Discovery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 9. Global Fragment-based Drug Discovery Market Share by Regions (2021-2026)
Table 10. Fragment-based Drug Discovery Market Market Trends
Table 11. Fragment-based Drug Discovery Market Drivers
Table 12. Fragment-based Drug Discovery Market Challenges
Table 13. Fragment-based Drug Discovery Market Restraints
Table 14. Global Fragment-based Drug Discovery Revenue by Players (2015-2020) (US$ Million)
Table 15. Global Fragment-based Drug Discovery Market Share by Players (2015-2020)
Table 16. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2019)
Table 17. Global Fragment-based Drug Discovery by Players Market Concentration Ratio (CR5 and HHI)
Table 18. Key Players Headquarters and Area Served
Table 19. Key Players Fragment-based Drug Discovery Product Solution and Service
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Fragment-based Drug Discovery Market Size by Type (2015-2020) (US$ Million)
Table 22. Global Fragment-based Drug Discovery Revenue Market Share by Type (2015-2020)
Table 23. Global Fragment-based Drug Discovery Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 24. Global Fragment-based Drug Discovery Market Size Share by Application (2015-2020) (US$ Million)
Table 25. Global Fragment-based Drug Discovery Revenue Market Share by Application (2015-2020)
Table 26. Global Fragment-based Drug Discovery Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 27. North America Fragment-based Drug Discovery Market Size by Type (2015-2020) (US$ Million)
Table 28. North America Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 29. North America Fragment-based Drug Discovery Market Size by Application (2015-2020) (US$ Million)
Table 30. North America Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 31. North America Fragment-based Drug Discovery Market Size by Country (US$ Million) (2015-2020)
Table 32. North America Fragment-based Drug Discovery Market Share by Country (2015-2020)
Table 33. Europe Fragment-based Drug Discovery Market Size by Type (2015-2020) (US$ Million)
Table 34. Europe Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 35. Europe Fragment-based Drug Discovery Market Size by Application (2015-2020) (US$ Million)
Table 36. Europe Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 37. Europe Fragment-based Drug Discovery Market Size by Country (US$ Million) (2015-2020)
Table 38. Europe Fragment-based Drug Discovery Market Share by Country (2015-2020)
Table 39. Asia-Pacific Fragment-based Drug Discovery Market Size by Type (2015-2020) (US$ Million)
Table 40. Asia-Pacific Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 41. Asia-Pacific Fragment-based Drug Discovery Market Size by Application (2015-2020) (US$ Million)
Table 42. Asia-Pacific Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 43. Asia-Pacific Fragment-based Drug Discovery Market Size by Region (US$ Million) (2015-2020)
Table 44. Asia-Pacific Fragment-based Drug Discovery Market Share by Region (2015-2020)
Table 45. Latin America Fragment-based Drug Discovery Market Size by Type (2015-2020) (US$ Million)
Table 46. Latin America Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 47. Latin America Fragment-based Drug Discovery Market Size by Application (2015-2020) (US$ Million)
Table 48. Latin America Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 49. Latin America Fragment-based Drug Discovery Market Size by Country (US$ Million) (2015-2020)
Table 50. Latin America Fragment-based Drug Discovery Market Share by Country (2015-2020)
Table 51. Middle East & Africa Fragment-based Drug Discovery Market Size by Type (2015-2020) (US$ Million)
Table 52. Middle East & Africa Fragment-based Drug Discovery Market Share by Type (2015-2020)
Table 53. Middle East & Africa Fragment-based Drug Discovery Market Size by Application (2015-2020) (US$ Million)
Table 54. Middle East & Africa Fragment-based Drug Discovery Market Share by Application (2015-2020)
Table 55. Middle East & Africa Fragment-based Drug Discovery Market Size by Country (US$ Million) (2015-2020)
Table 56. Middle East & Africa Fragment-based Drug Discovery Market Share by Country (2015-2020)
Table 57. Astex Pharmaceuticals Company Details
Table 58. Astex Pharmaceuticals Business Overview
Table 59. Astex Pharmaceuticals Fragment-based Drug Discovery Product
Table 60. Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 61. Astex Pharmaceuticals Recent Development
Table 62. Alveus Pharmaceuticals Company Details
Table 63. Alveus Pharmaceuticals Business Overview
Table 64. Alveus Pharmaceuticals Fragment-based Drug Discovery Product
Table 65. Alveus Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 66. Alveus Pharmaceuticals Recent Development
Table 67. Beactica Company Details
Table 68. Beactica Business Overview
Table 69. Beactica Fragment-based Drug Discovery Product
Table 70. Beactica Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 71. Beactica Recent Development
Table 72. Charles River Laboratories Company Details
Table 73. Charles River Laboratories Business Overview
Table 74. Charles River Laboratories Fragment-based Drug Discovery Product
Table 75. Charles River Laboratories Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 76. Charles River Laboratories Recent Development
Table 77. Crown Bioscience Company Details
Table 78. Crown Bioscience Business Overview
Table 79. Crown Bioscience Fragment-based Drug Discovery Product
Table 80. Crown Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 81. Crown Bioscience Recent Development
Table 82. Emerald BioStructures Company Details
Table 83. Emerald BioStructures Business Overview
Table 84. Emerald BioStructures Fragment-based Drug Discovery Product
Table 85. Emerald BioStructures Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 86. Emerald BioStructures Recent Development
Table 87. Evotec Company Details
Table 88. Evotec Business Overview
Table 89. Evotec Fragment-based Drug Discovery Product
Table 90. Evotec Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 91. Evotec Recent Development
Table 92. Kinetic Discovery Business Overview
Table 93. Kinetic Discovery Fragment-based Drug Discovery Product
Table 94. Kinetic Discovery Company Details
Table 95. Kinetic Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 96. Kinetic Discovery Recent Development
Table 97. Proteros Fragments Company Details
Table 98. Proteros Fragments Business Overview
Table 99. Proteros Fragments Fragment-based Drug Discovery Product
Table 100. Proteros Fragments Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 101. Proteros Fragments Recent Development
Table 102. Sprint Bioscience Company Details
Table 103. Sprint Bioscience Business Overview
Table 104. Sprint Bioscience Fragment-based Drug Discovery Product
Table 105. Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 106. Sprint Bioscience Recent Development
Table 107. Structure Based Design Company Details
Table 108. Structure Based Design Business Overview
Table 109. Structure Based Design Fragment-based Drug Discovery Product
Table 110. Structure Based Design Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 111. Structure Based Design Recent Development
Table 112. Sygnature Discovery Company Details
Table 113. Sygnature Discovery Business Overview
Table 114. Sygnature Discovery Fragment-based Drug Discovery Product
Table 115. Sygnature Discovery Revenue in Fragment-based Drug Discovery Business (2015-2020) (US$ Million)
Table 116. Sygnature Discovery Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fragment-based Drug Discovery Market Share by Type: 2020 VS 2026
Figure 2. Fragment Screening Features
Figure 3. Fragment Optimization Features
Figure 4. Global Fragment-based Drug Discovery Market Share by Application: 2020 VS 2026
Figure 5. Academic and Research Institutions Case Studies
Figure 6. Biopharmaceutical Companies Case Studies
Figure 7. Contract Research Organizations (CROs) Case Studies
Figure 8. Fragment-based Drug Discovery Report Years Considered
Figure 9. Global Fragment-based Drug Discovery Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Fragment-based Drug Discovery Market Share by Regions: 2020 VS 2026
Figure 11. Global Fragment-based Drug Discovery Market Share by Regions (2021-2026)
Figure 12. Global Fragment-based Drug Discovery Market Share by Players in 2019
Figure 13. Global Top Fragment-based Drug Discovery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fragment-based Drug Discovery as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Fragment-based Drug Discovery Revenue in 2019
Figure 15. North America Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Fragment-based Drug Discovery Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 41. Alveus Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 42. Beactica Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 43. Charles River Laboratories Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 44. Crown Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 45. Emerald BioStructures Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 46. Evotec Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 47. Kinetic Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 48. Proteros Fragments Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 49. Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 50. Structure Based Design Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 51. Sygnature Discovery Revenue Growth Rate in Fragment-based Drug Discovery Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global High Content Screening Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......

Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......

Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......

Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029

Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88

Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......

Global High Content Screening Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110

High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......

Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115

High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......

Global Fragment-based Drug Discovery Market Insights, Forecast to 2029

Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......

High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146

The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs